Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients.
作者信息
Sharma Vagisha, Tuli Isha Preet
机构信息
Intern, Vardhaman Mahaveer Medical College and Safdarjung Hospital, New Delhi, India.
Department of ENT, Vardhaman Mahaveer Medical College and Safdarjung Hospital, New Delhi, India.
出版信息
J Family Med Prim Care. 2023 Jul;12(7):1472-1473. doi: 10.4103/jfmpc.jfmpc_636_23. Epub 2023 Jul 14.
Abstract
摘要
相似文献
1
Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients.
J Family Med Prim Care. 2023 Jul;12(7):1472-1473. doi: 10.4103/jfmpc.jfmpc_636_23. Epub 2023 Jul 14.
2
COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Indian J Pharmacol. 2021 Nov-Dec;53(6):499-510. doi: 10.4103/ijp.ijp_839_21.
3
Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Indian J Ophthalmol. 2022 Aug;70(8):3096-3101. doi: 10.4103/ijo.IJO_448_22.
4
Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
J Mycol Med. 2022 May;32(2):101238. doi: 10.1016/j.mycmed.2021.101238. Epub 2021 Dec 25.
5
Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
Indian J Ophthalmol. 2023 Jan;71(1):39-56. doi: 10.4103/ijo.IJO_1219_22.
6
Sinonasal and Orbital Imaging Findings in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of COVID-19: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
Cureus. 2023 Jul 30;15(7):e42674. doi: 10.7759/cureus.42674. eCollection 2023 Jul.
7
COVID-19-Related Rhino-Orbito-Cerebral Mucormycosis Complicated by the Optic Nerve and Optic Tract Ischemia With Ischemic Neuropathy.
Cureus. 2022 Mar 11;14(3):e23068. doi: 10.7759/cureus.23068. eCollection 2022 Mar.
8
Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India.
Med Mycol. 2023 Jul 6;61(7). doi: 10.1093/mmy/myad067.
9
A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Orbit. 2023 Feb;42(1):30-41. doi: 10.1080/01676830.2021.2020851. Epub 2022 Feb 22.
10
The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.
Semin Ophthalmol. 2022 Apr 3;37(3):279-283. doi: 10.1080/08820538.2021.1946094. Epub 2021 Jul 14.
引用本文的文献
1
Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study.
Sci Rep. 2025 May 8;15(1):16088. doi: 10.1038/s41598-025-98926-9.
本文引用的文献
1
Trends of rhino-orbito-cerebral mucormycosis in COVID-19 patients: An observational study.
J Family Med Prim Care. 2022 Dec;11(12):7891-7896. doi: 10.4103/jfmpc.jfmpc_1433_22. Epub 2023 Jan 17.
2
Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.
Indian J Ophthalmol. 2021 Jun;69(6):1361-1365. doi: 10.4103/ijo.IJO_1165_21.
3
Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India.
J Fungi (Basel). 2018 Apr 6;4(2):46. doi: 10.3390/jof4020046.
Zotero 插件